BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang H, Tang QF, Sun MY, Zhang CY, Zhu JY, Shen YL, Zhao B, Shao ZY, Zhang LJ, Zhang H. ARHGAP9 suppresses the migration and invasion of hepatocellular carcinoma cells through up-regulating FOXJ2/E-cadherin. Cell Death Dis 2018;9:916. [PMID: 30206221 DOI: 10.1038/s41419-018-0976-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Liu Z, Liu T, Li W, Li J, Wang C, Zhang K. Insights into the antitumor mechanism of ginsenosides Rg3. Mol Biol Rep 2021;48:2639-52. [PMID: 33661439 DOI: 10.1007/s11033-021-06187-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 He X, Zou H, Wang F. SOX4-induced upregulation of ARHGAP9 promotes the progression of acute myeloid leukemia. Drug Dev Res 2021. [PMID: 34159626 DOI: 10.1002/ddr.21837] [Reference Citation Analysis]
3 Song WP, Zheng S, Yao HJ, Zhou XF, Li R, Zhang CY, Zhao JY, Wang LW, Shao RG, Li L. Different transcriptome profiles between human retinoblastoma Y79 cells and an etoposide-resistant subline reveal a chemoresistance mechanism. BMC Ophthalmol 2020;20:92. [PMID: 32143590 DOI: 10.1186/s12886-020-01348-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
4 Han C, He S, Wang R, Gao X, Wang H, Qiao J, Meng X, Li Y, Yu L. The role of ARHGAP9: clinical implication and potential function in acute myeloid leukemia. J Transl Med 2021;19:65. [PMID: 33579308 DOI: 10.1186/s12967-021-02733-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Liu G, Li J, Zhang CY, Huang DY, Xu JW. ARHGAP20 Expression Inhibited HCC Progression by Regulating the PI3K-AKT Signaling Pathway. J Hepatocell Carcinoma 2021;8:271-84. [PMID: 33907697 DOI: 10.2147/JHC.S298554] [Reference Citation Analysis]
6 Hiwasa T, Wang H, Goto KI, Mine S, Machida T, Kobayashi E, Yoshida Y, Adachi A, Matsutani T, Sata M, Yamagishi K, Iso H, Sawada N, Tsugane S, Kunimatsu M, Kamitsukasa I, Mori M, Sugimoto K, Uzawa A, Muto M, Kuwabara S, Kobayashi Y, Ohno M, Nishi E, Hattori A, Yamamoto M, Maezawa Y, Kobayashi K, Ishibashi R, Takemoto M, Yokote K, Takizawa H, Kishimoto T, Matsushita K, Kobayashi S, Nomura F, Arasawa T, Kagaya A, Maruyama T, Matsubara H, Tomiita M, Hamanaka S, Imai Y, Nakagawa T, Kato N, Terada J, Matsumura T, Katsumata Y, Naito A, Tanabe N, Sakao S, Tatsumi K, Ito M, Shiratori F, Sumazaki M, Yajima S, Shimada H, Shirouzu M, Yokoyama S, Kudo T, Doi H, Iwase K, Ashino H, Li SY, Kubota M, Tomiyoshi G, Shinmen N, Nakamura R, Kuroda H, Iwadate Y. Serum anti-DIDO1, anti-CPSF2, and anti-FOXJ2 antibodies as predictive risk markers for acute ischemic stroke. BMC Med 2021;19:131. [PMID: 34103026 DOI: 10.1186/s12916-021-02001-9] [Reference Citation Analysis]
7 Song Y, Pan Y, Liu J. The relevance between the immune response-related gene module and clinical traits in head and neck squamous cell carcinoma. Cancer Manag Res 2019;11:7455-72. [PMID: 31496804 DOI: 10.2147/CMAR.S201177] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
8 Hong H, Baatar D, Hwang SG. Anticancer Activities of Ginsenosides, the Main Active Components of Ginseng. Evid Based Complement Alternat Med 2021;2021:8858006. [PMID: 33623532 DOI: 10.1155/2021/8858006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Zhong X, Luo M, Wu Y, Zhou X, Yu X, Liu L, Chen S. Genetic variants in STAT4 and their interactions with environmental factors for the incidence of hepatocellular carcinoma. Cancer Biomark 2021;32:3-9. [PMID: 33896832 DOI: 10.3233/CBM-203162] [Reference Citation Analysis]
10 Sprenkeler EGG, Henriet SSV, Tool ATJ, Kreft IC, van der Bijl I, Aarts CEM, van Houdt M, Verkuijlen PJJH, van Aerde K, Jaspers G, van Heijst A, Koole W, Gardeitchik T, Geissler J, de Boer M, Tol S, Bruggeman CW, van Alphen FPJ, Verhagen HJMP, van den Akker E, Janssen H, van Bruggen R, van den Berg TK, Liem KD, Kuijpers TW. MKL1 deficiency results in a severe neutrophil motility defect due to impaired actin polymerization. Blood 2020;135:2171-81. [PMID: 32128589 DOI: 10.1182/blood.2019002633] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 13.0] [Reference Citation Analysis]
11 Chen WX, Lou M, Cheng L, Qian Q, Xu LY, Sun L, Zhu YL, Dai H. Bioinformatics analysis of potential therapeutic targets among ARHGAP genes in breast cancer. Oncol Lett 2019;18:6017-25. [PMID: 31788076 DOI: 10.3892/ol.2019.10949] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
12 Nahalka J. Theoretical Analysis of S, M and N Structural Proteins by the Protein-RNA Recognition Code Leads to Genes/proteins that Are Relevant to the SARS-CoV-2 Life Cycle and Pathogenesis. Front Genet 2021;12:763995. [PMID: 34659373 DOI: 10.3389/fgene.2021.763995] [Reference Citation Analysis]